Remove for-authors
article thumbnail

CMS finalizes rule tightening prior authorization turnaround for insurers

Health Care Dive

Payers have new deadlines to issue prior authorization decisions — 72 hours for urgent requests and seven days for non-urgent ones — that should cut back coverage determination limbo for patients.

315
315
article thumbnail

UnitedHealthcare defends controversial prior authorization policy for colonoscopies

Fierce Healthcare

UnitedHealthcare defends controversial prior authorization policy for colonoscopies fdiamond Tue, 05/16/2023 - 16:43

318
318
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CMS proposes new prior authorization requirements for payers, including MA plans

Health Care Dive

Regulators want payers to issue coverage decisions within 72 hours for urgent prior authorization requests — but the final turnaround time could be even shorter.

article thumbnail

UnitedHealthcare, docs still at odds over prior authorization policy for colonoscopies

Fierce Healthcare

UnitedHealthcare, docs still at odds over prior authorization policy for colonoscopies fdiamond Tue, 05/30/2023 - 17:17

307
307
article thumbnail

Author Health launches with $115M to care for seniors with serious mental illnesses, substance abuse disorders

Fierce Healthcare

Author Health banked $115 million for its new platform offering care and treatment for Medicare Advantage members with serious mental illness and substance use disorders. Author Health banks $115 million for its new platform offering care and treatment for Medicare Advantage members with serious mental illness and substance use disorders.

article thumbnail

HHS' proposed HTI-1 rule draws criticism for what's excluded—electronic prior authorization

Fierce Healthcare

HHS' proposed HTI-1 rule draws criticism for what's excluded—electronic prior authorization aburky Mon, 05/08/2023 - 16:18

241
241
article thumbnail

Cue Health wins first non-emergency authorization for COVID test

Health Care Dive

The FDA’s marketing authorization for Cue’s COVID-19 molecular test could boost consumer access, but the company faces strong competition from more established diagnostic firms.

159
159